Katrina Sharples

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients

M. Brimble, V. Hinder, I. Hermans, 2018, Cancer Immunology, Immunotherapy.

High CYP2C19 phenotypic variability in gastrointestinal cancer patients

N. Helsby, W. Lo, M. Findlay, 2015, Cancer Chemotherapy and Pharmacology.